CI 10020

CI 10020 and pregnancy

Caution Advised

• Absorbed into the body

CI 10020 is a synthetic azo dye used to add orange color to cosmetic products. Azo dyes are a large class of synthetic colorants that can potentially be absorbed through skin, though absorption rates vary. While specific pregnancy safety studies on CI 10020 are limited, some concerns exist with azo dyes as a class during pregnancy. Azo dyes can be metabolized into aromatic amines, and some compounds in this chemical family have shown reproductive toxicity in animal studies, though at doses much higher than cosmetic exposure. The EU has placed restrictions on its use, limiting it to rinse-off products or leave-on products not near mucous membranes, which suggests regulatory caution. Due to limited specific safety data for pregnancy and the general precautionary approach to synthetic colorants during this time, many healthcare providers recommend choosing products without synthetic dyes when possible. This is more of a precautionary stance than evidence of harm. Rinse-off products containing CI 10020 are lower risk than leave-on formulations due to minimal contact time and reduced absorption potential.

CI 10020 and breastfeeding

Safe to Use

CI 10020 is a colorant used at low concentrations in cosmetics. While azo dyes can theoretically be absorbed through skin, the amounts used in topical cosmetics result in minimal systemic exposure. There is no specific data on CI 10020 transfer into breast milk from topical cosmetic use. Given that colorants are typically used at very low concentrations (usually less than 1%) and the ingredient's restricted use in EU regulations, the risk to breastfed infants from maternal cosmetic use is considered low. Breastfeeding mothers can generally use products containing CI 10020, particularly rinse-off products where exposure is minimal. As with any cosmetic, avoid application near the breast or nipple area. Those with sensitive skin may experience irritation, but this is a skin tolerance issue rather than a breastfeeding-specific concern.

CI 10020 and postpartum

Safe to Use

• Irritant

For postpartum women not breastfeeding, CI 10020 poses minimal concerns beyond its potential for skin irritation in sensitive individuals. As a colorant, it provides aesthetic appeal but no functional skincare benefits. Postpartum skin can be more sensitive due to hormonal fluctuations, so women experiencing increased skin reactivity may want to avoid products with synthetic colorants if irritation occurs. However, colorants are typically used at very low concentrations and are often well-tolerated.

CI 10020 and trying to conceive

Safe to Use

While CI 10020 is rated medium-risk during confirmed pregnancy due to limited safety data on azo dyes, women trying to conceive can generally use products containing this colorant at cosmetic concentrations. There is no evidence of fertility effects from topical cosmetic use. Some women prefer to adopt pregnancy-safe routines while trying to conceive to avoid needing to switch products after conception. In that case, choosing products with natural colorants or no added colorants provides additional peace of mind. However, there is no evidence that CI 10020 at cosmetic concentrations affects conception or early pregnancy development.

CI 10020 and PCOS

Safe to Use

CI 10020 has no known hormonal activity or effects on androgens, insulin sensitivity, or other metabolic factors related to PCOS. It functions purely as a cosmetic colorant. For women with PCOS, there are no condition-specific concerns with this ingredient beyond general skin tolerance. The ingredient does not affect acne, oil production, or any other dermatological symptoms associated with PCOS. There is no evidence that CI 10020 interferes with PCOS management or interacts with PCOS medications. Women with PCOS can use products containing this colorant, though those prone to irritation should monitor their skin's response.

CI 10020 and general use

Safe to Use

• Common allergen
• Irritant

CI 10020 (Acid Orange 3) is a synthetic azo dye used to add orange color to cosmetic formulations. Colorants like this are used at very low concentrations (typically under 1%) to provide aesthetic appeal. The ingredient can cause skin irritation and allergic reactions in sensitive individuals. The EU Scientific Committee on Consumer Safety has evaluated it and permits its use with restrictions—it's allowed in rinse-off products and in leave-on products that don't contact mucous membranes, but not for use around the eyes. For most people, CI 10020 is well-tolerated when used within regulatory limits. Those with sensitive skin, a history of dye allergies, or azo dye sensitivity should be cautious and may want to avoid products containing synthetic colorants. Rinse-off products pose less risk than leave-on formulations due to minimal skin contact time.

Everything else flagged for the same profiles

• Flagged in pregnancy

Related ingredients

Ingredients suggested in place of CI 10020, each one with its own page here.

• Iron Oxides
• Mica

Ingredients that raise the same concerns.

• Parfum/FragranceIrritant, Common allergen, Absorbed into the body
• Lavandula Angustifolia OilIrritant, Common allergen, Absorbed into the body
• Melaleuca Alternifolia Leaf OilIrritant, Common allergen, Absorbed into the body
• EugenolIrritant, Common allergen, Absorbed into the body
• Rosmarinus Officinalis Leaf OilIrritant, Common allergen, Absorbed into the body
• DMDM HydantoinIrritant, Common allergen, Absorbed into the body

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.